Insulin degludec structure
Insulin degludec
(1A-21A),(1B-29B)-insulin (human), 29B-(N6-(N-(15-carboxy-1- oxopentadecyl)-L-gamma- glutamyl)-L-lysine)-;degludec;insulin degludec;UNII-54Q18076QB;54Q18076QB;Tresiba;Insulin degludec [USAN:INN];NN 1250
Find 4 Related Holders
Novo Nordisk (China) Pharmaceuticals Co., Ltd.
China
China
API Registration Country
API Active
-
Founded in:
1994-08-22 -
Country:
China -
Address:
Nanhai Road, Tianjin Economic and Technological Development Zone -
Tax NO.:
91120116600537733W -
Registered Funds:
$557.3 million -
Email:
CHONGQING CHEN'AN BIOPHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
YIFAN PHARMACEUTICAL (SHANGHAI) CO LTD
United States
United States
API Registration Country
API Active
HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
Recommended Suppliers of Insulin degludec
-
Henan Lihao Chem Plant Limited
CN1 YR
Contact Supplier -
Zhuhai Gene-Biocon Biological Technology Co., Ltd.
CN1 YR
Contact Supplier -
HANGZHOU LEAP CHEM CO., LTD.
CN1 YR
Contact Supplier -
Henan Lihao Chem Plant Limited
CN1 YR
Contact Supplier -
Henan Lihao Chem Plant Limited
CN1 YR
Contact Supplier